BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34270097)

  • 21. Metabolic and magnetic resonance imaging: complementary modalities for the preoperative assessment of lateral pelvic lymph nodes in rectal cancer.
    Cribb BI; Kong JC; Kay JS; Tan TH; Noe GD; Gest B; Lee AB; Oon SF; Warrier SK; Heriot AG
    ANZ J Surg; 2023 Jan; 93(1-2):196-205. PubMed ID: 36074654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer.
    Dinaux AM; Leijssen L; Bordeianou LG; Kunitake H; Amri R; Berger DL
    Surgery; 2018 Apr; 163(4):784-788. PubMed ID: 29277386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
    Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
    World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival.
    Karimi F; Tabriz HM; Amoli HA; Nazar E; Vaezi AA
    Indian J Pathol Microbiol; 2022; 65(1):49-54. PubMed ID: 35074965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of internal iliac and obturator lymph nodes in mid-low rectal cancer.
    Xiao T; Chen J; Liu Q
    World J Surg Oncol; 2024 Jun; 22(1):153. PubMed ID: 38863003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 28. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
    Lee WC; Yusof MM; Lau FN; Phua VC
    Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy.
    Wang P; Zhou S; Zhou H; Liang J; Zhou Z
    Colorectal Dis; 2019 Jul; 21(7):791-796. PubMed ID: 30801862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
    Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ
    Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
    Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
    Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten-year survival after pathologic complete response in rectal adenocarcinoma.
    Sell NM; Qwaider YZ; Goldstone RN; Cauley CE; Cusack JC; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
    J Surg Oncol; 2021 Jan; 123(1):293-298. PubMed ID: 33022797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
    Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
    Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.
    Miller ED; Robb BW; Cummings OW; Johnstone PA
    Dis Colon Rectum; 2012 Sep; 55(9):1002-7. PubMed ID: 22874609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
    Park H; Kim KA; Jung JH; Rhie J; Choi SY
    Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma.
    Tsai CJ; Crane CH; Skibber JM; Rodriguez-Bigas MA; Chang GJ; Feig BW; Eng C; Krishnan S; Maru DM; Das P
    Cancer; 2011 Aug; 117(16):3713-22. PubMed ID: 21328329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.